UPDATE: Auriga Raises PT on Thermo Fisher Scientific to $73 (TMO)

Auriga is out with its report today on Thermo Fisher Scientific TMO, raising its PT to $73. In a note to clients, Auriga writes, "Given TMO's solid end market demand, continued margin expansion, strong cash flow and attractive product portfolio, we view TMO's current discount (14x) to the sector median (19.5x) as unwarranted. Our $73 price target is based on 16x our new 2012 estimate of $4.70, discounted 1 year at 10%." Auriga maintains Buy on Thermo Fisher Scientific. Shares of TMO closed Tuesday at $61.08.